[Guidelines for the use of contrast agents in ultrasound].

[1]  D. Cosgrove,et al.  Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? , 2002, European journal of radiology.

[2]  E. Hahn,et al.  [Detection of liver metastases--comparison of contrast--enhanced ultrasound using first versus second generation contrast agents]. , 2003, Ultraschall in der Medizin.

[3]  J. Llovet,et al.  Hepatocellular carcinoma: present status and future prospects. , 2003, Journal of hepatology.

[4]  E. Leen.  The role of contrast-enhanced ultrasound in the characterisation of focal liver leasions , 2001, European Radiology.

[5]  Matthew Bruce,et al.  Ultrasound Contrast Imaging Research , 2003, Ultrasound quarterly.

[6]  J. Hohmann,et al.  Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. , 2003, European journal of radiology.

[7]  C. Fellbaum,et al.  Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A , 2004, Gut.

[8]  L. Dalla Palma,et al.  Detection of liver metastases with pulse inversion harmonic imaging: Preliminary results , 1999, European Radiology.

[9]  C. Chin,et al.  Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents , 1999, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[10]  Characteristics of hepatic hemangiomas at contrast-enhanced harmonic US. , 2001, Radiology.

[11]  J. Bruix,et al.  Prognostic prediction and treatment strategy in hepatocellular carcinoma , 2002, Hepatology.

[12]  Thomas Albrecht,et al.  Charakterisierung fokaler Leberläsionen mit kontrastmittelgestütztem „low MI real time” Ultraschall und SonoVue , 2003 .

[13]  L Solbiati,et al.  Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[14]  G. Schmid-Schönbein,et al.  Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats. , 2002, Radiology.

[15]  V L Newhouse,et al.  Second harmonic ultrasonic blood perfusion measurement. , 1993, Ultrasound in medicine & biology.

[16]  Carlo Bartolozzi,et al.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. , 2003, Radiology.

[17]  D O Cosgrove,et al.  Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. , 2000, Radiology.

[18]  P. Burns,et al.  Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. , 2000, Radiology.

[19]  P. Burns,et al.  Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. , 2002, Radiology.

[20]  Michel Claudon,et al.  Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts , 2001, European Radiology.

[21]  E. Hahn,et al.  Dynamic contrast-enhanced power Doppler sonography improves the differential diagnosis of liver lesions , 2001, International Journal of Colorectal Disease.

[22]  T. de Baère,et al.  Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. , 2000, AJR. American journal of roentgenology.

[23]  Thomas Albrecht,et al.  Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. , 2003, Radiology.

[24]  R. Pozzi Mucelli,et al.  [Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue]. , 2004, La Radiologia medica.

[25]  C. Bartolozzi,et al.  Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. , 2001, AJR. American journal of roentgenology.

[26]  D O Cosgrove,et al.  Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience. , 2001, Radiology.

[27]  K. Wolf,et al.  Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and sonoVue , 2003, European Radiology.

[28]  B. Lüderitz,et al.  Real‐Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power , 1999, Echocardiography.

[29]  K J Wolf,et al.  Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. , 2001, AJR. American journal of roentgenology.

[30]  F. Stacul,et al.  Characterization of focal liver lesions with pulse inversion harmonic imaging (PIHI) using a second generation US contrast agent. , 2002, Academic radiology.

[31]  P. Burns.  Contrast Ultrasound Technology , 2003 .

[32]  E. Leen,et al.  Ultrasound contrast agents for hepatic imaging with nonlinear modes. , 2003, Current problems in diagnostic radiology.

[33]  D. Cosgrove,et al.  Stimulierte akustische Emission mit dem Ultraschall-Kontrastmittel Levovist: Ein klinisch nutzbarer Kontrasteffekt mit leberspezifischen Eigenschaften , 2000 .

[34]  M. Bahner,et al.  Comparison of B-mode and conventional colour/power Doppler ultrasound, contrast-enhanced Doppler ultrasound and spiral CT in the diagnosis of focal lesions of the liver: Results of a multicentre study. , 2002, Ultraschall in der Medizin.